AMICUS THERAPEUTICS, INC. — Director's Dealing 2020

Jun 17, 2020

SEC Form 4/A — Form 4/A

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2019-06-27

Reporting Person: WHITMAN BURKE W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-06-27	Common Stock	A	16667	$0.00	Acquired	16667	Direct

Footnotes

F1: Granted in the form of Restricted Stock Units ("RSUs") these RSUs vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter over a three year period.